Anixa Biosciences Aktie

2,44 EUR -0,02 EUR -0,81 %

20.02.2026

BMN

2,89 USD -0,04 USD -1,37 %

nachbörslich20.02.2026

BTT

Anixa Biosciences jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

Marktkap.82,90 Mio. EUR

Div. Rendite0,00%

WKNA2N6ZF

ISINUS03528H1095

SymbolANIX

Anixa Biosciences Aktien News

Sortieren:Datum Meistgelesen

14.04.25PR NewswireAnixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio

09.04.25PR NewswireAnixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology

09.04.25BenzingaEXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent

01.04.25PR NewswireAnixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th

25.03.25PR NewswireAnixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines

25.03.25BenzingaEXCLUSIVE: Anixa Biosciences Inks Letter of Intent with Austria-Based VERDI Solutions To Develop AI-Guided Personalized Cancer Vaccines

24.03.25PR NewswireAnixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine

24.03.25BenzingaEXCLUSIVE: Anixa Biosciences Poised To Receive US Patent For Ovarian Cancer Vaccine

17.03.25PR NewswireAnixa Biosciences CEO to Present at the 2025 CAGLA NeauxCancer Conference on March 28th

14.03.25finanzen.netAnixa Biosciences: So viel setzte das Unternehmen zuletzt um

10.03.25PR NewswireAnixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties

03.03.25PR NewswireAnixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th

26.02.25PR NewswireAnixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial

25.02.25PR NewswireAnixa Biosciences' Breast Cancer Vaccine was Featured on Fox News' "America Reports"

24.02.25PR NewswireAnixa Biosciences Featured in Breaking Cancer News Article on Novel CAR-T Therapy for Ovarian Cancer

18.02.25PR NewswireAnixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial

14.02.25PR NewswireAnixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview

11.02.25PR NewswireAnixa Biosciences to Present at the 18th Annual European Life Sciences CEO Forum

04.02.25PR NewswireAnixa Biosciences' Chairman & CEO Dr. Amit Kumar Featured on CW39's H-Town Live to Discuss the Future of Breast Cancer Prevention

21.01.25PR NewswireAnixa Biosciences CEO Provides Letter to Shareholders

13.01.25finanzen.netAnixa Biosciences stellte Ergebnisse des abgelaufenen Quartals vor

04.12.24PR NewswireAnixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10

22.11.24PR NewswireAnixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset

18.11.24PR NewswireAnixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial

08.11.24PR NewswireAnixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

06.11.24PR NewswireAnixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of its Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

31.10.24PR NewswireAnixa Biosciences to Present at the Sidoti Micro-Cap Virtual Conference on November 13 & 14, 2024

28.10.24PR NewswireAnixa Biosciences and Cleveland Clinic to Present Additional Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting

15.10.24PR NewswireAnixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical Trial

07.10.24PR NewswireAnixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development

30.09.24PR NewswireAnixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial

24.09.24PR NewswireAnixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine

08.09.24finanzen.netAnixa Biosciences hat Bilanz für das abgelaufene Quartal gezogen

03.09.24PR NewswireAnixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium

26.08.24PR NewswireAnixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

29.07.24PR NewswireAnixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting

23.07.24PR NewswireAnixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy

17.07.24PR NewswireAnixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology

15.07.24PR NewswireAnixa Biosciences Announces $5 Million Share Repurchase Program

24.06.24PR NewswireAnixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial

Anixa Biosciences News

Anixa Biosciences News: auf dieser Seite finden Sie alle Anixa Biosciences News und Nachrichten zur Anixa Biosciences Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Anixa Biosciences News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Anixa Biosciences News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.